Literature DB >> 2281431

Cystic fibrosis. 2. Lung injury in cystic fibrosis.

J S Elborn1, D J Shale.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2281431      PMCID: PMC462848          DOI: 10.1136/thx.45.12.970

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  35 in total

1.  Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases.

Authors:  E H Oppenheimer; J R Esterly
Journal:  Perspect Pediatr Pathol       Date:  1975

2.  Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection.

Authors:  D E Roberts; P Cole
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

3.  Bactericidal mechanisms of the human neutrophil. An integrated biochemical and morphological model.

Authors:  N Borregaard
Journal:  Scand J Haematol       Date:  1984-03

Review 4.  The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.

Authors:  M I Marks
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

5.  Pseudomonas colonization in cystic fibrosis. A study of 160 patients.

Authors:  L L Kulczycki; T M Murphy; J A Bellanti
Journal:  JAMA       Date:  1978-07-07       Impact factor: 56.272

6.  Haemophilus from the lower respiratory tract of patients with cystic fibrosis.

Authors:  N Hoiby; M Kilian
Journal:  Scand J Respir Dis       Date:  1976

7.  Collagen of the dystrophic hamster diaphragm.

Authors:  N S al-Zaid; M S al-Adnani; K A Gumaa
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

8.  Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.

Authors:  N T Petersen; N Høiby; C H Mordhorst; K Lind; E W Flensborg; B Bruun
Journal:  Acta Paediatr Scand       Date:  1981-09

9.  Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance.

Authors:  S S Long; M J Teter; P H Gilligan
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

10.  Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis.

Authors:  M Szaff; N Høiby
Journal:  Acta Paediatr Scand       Date:  1982-09
View more
  16 in total

1.  Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.

Authors:  D Dacheux; I Attree; B Toussaint
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Viral infections: a role in the lung disease of cystic fibrosis?

Authors:  D J Shale
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

3.  Peripheral nerve dysfunction in adult patients with cystic fibrosis.

Authors:  J I O'Riordan; J Hayes; M X Fitzgerald; J Redmond
Journal:  Ir J Med Sci       Date:  1995 Jul-Sep       Impact factor: 1.568

4.  Calprotectin as a marker of inflammation in cystic fibrosis.

Authors:  B E Golden; P A Clohessy; G Russell; M K Fagerhol
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

5.  Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system.

Authors:  D Dacheux; I Attree; C Schneider; B Toussaint
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.

Authors:  William R Hunt; Susu M Zughaier; Dana E Guentert; Melissa A Shenep; Michael Koval; Nael A McCarty; Jason M Hansen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

7.  Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.

Authors:  Holly K Huse; Taejoon Kwon; James E A Zlosnik; David P Speert; Edward M Marcotte; Marvin Whiteley
Journal:  MBio       Date:  2010-09-21       Impact factor: 7.867

Review 8.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

9.  Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.

Authors:  S H Thomas; M J O'Doherty; A Graham; C J Page; P Blower; D M Geddes; T O Nunan
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

10.  Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.

Authors:  R F Taylor; M E Hodson; T L Pitt
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.